Literature DB >> 30447775

Graft Dysfunction and Management in Liver Transplantation.

Beverley Kok1, Victor Dong1, Constantine J Karvellas2.   

Abstract

Graft dysfunction of the liver allograft manifests across a spectrum in both timing posttransplantation and clinical presentation. This can range from mild transient abnormalities of liver tests to acute liver failure potentially leading to graft failure. The causes of graft dysfunction can be divided into those resulting in early and late graft dysfunction. Although nonspecific, liver biochemistry abnormalities are still the mainstay investigation used in monitoring for dysfunction. This article provides a summary of the main causes and management strategies for liver graft dysfunction in the early through late posttransplant stages.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholestasis; Graft dysfunction; Liver transplantation; Rejection

Mesh:

Year:  2018        PMID: 30447775     DOI: 10.1016/j.ccc.2018.08.002

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  3 in total

1.  Association between the donor to recipient ICG-PDR variation rate and the functional recovery of the graft after orthotopic liver transplantation: A case series.

Authors:  Vittorio Cherchi; Luigi Vetrugno; Giovanni Terrosu; Victor Zanini; Marco Ventin; Riccardo Pravisani; Francesco Tumminelli; Pier Paolo Brollo; Erica Boscolo; Roberto Peressutti; Dario Lorenzin; Tiziana Bove; Andrea Risaliti; Umberto Baccarani
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

2.  [Effect of artificial liver with double plasma molecular absorb system model on patients' platelets and corresponding treatment strategy].

Authors:  J F Jia; F Liang; J W Huang; H Wang; P Q Han
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-06-18

3.  Procalcitonin in early allograft dysfunction after orthotopic liver transplantation: a retrospective single centre study.

Authors:  Katja Frick; Elisabeth A Beller; Marit Kalisvaart; Philipp Dutkowski; Reto A Schüpbach; Stephanie Klinzing
Journal:  BMC Gastroenterol       Date:  2022-08-31       Impact factor: 2.847

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.